Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glargine vs Degludec in Glucocorticoid Induced Hyperglycemia
NCT07599891Phase 4Completed
- Sponsor
- Max Healthcare
- Start
- Sep 2023
- Primary completion
- Mar 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of insulin degludec in glucocorticoid-induced hyperglycemia (GIDM), sponsored by Max Healthcare. Started Sep 2023; status: completed.
02
Drugs
insulin degludec
03
Conditions
glucocorticoid-induced hyperglycemia (GIDM)
Beyond the preview
Go deeper on NCT07599891.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07599891.